Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| BATL | 8-K | neutral | 4/10 | Battalion Oil expanded its board from four to five directors and appointed John Brad Juneau as an independent director, | Oct 1, 2026 |
| LFWD | 8-K | neutral | 2/10 | Lifeward Ltd. filed an 8-K confirming that CFO Almog Adar's departure became effective September 30, 2026. Interim CEO J | Oct 1, 2026 |
| EMAT | 8-K | neutral | 4/10 | EMAT entered into a non-binding letter of intent with VIVIFY Technology for a proposed strategic energy collaboration. U | Oct 1, 2026 |
| CRMT | 8-K | bearish | 7/10 | America's Car-Mart (CRMT) obtained another one-week extension of its credit agreement waiver from Silver Point Finance, | Oct 1, 2026 |
| NSTS | 8-K | bullish | 7/10 | NSTS Bancorp, Inc. has been acquired by Brookfield Bancshares, Inc. in a two-step merger completed on October 1, 2026. S | Oct 1, 2026 |
| MTX | 8-K | neutral | 4/10 | Minerals Technologies Inc. announced the commencement of a private offering of $400 million aggregate principal amount o | Oct 1, 2026 |
| CWST | 8-K | bearish | 4/10 | Casella Waste Systems accelerated the closure of its NCES Landfill in Bethlehem, NH to December 31, 2026, a year earlier | Oct 1, 2026 |
| PARA | 8-K | neutral | 4/10 | CEO Joe Davy purchased 115,965 shares of Class B common stock for $81,176 ($0.70/share, at market price) via a private p | Oct 1, 2026 |
| OHI | 8-K | neutral | 2/10 | Omega Healthcare Investors announced the planned CEO succession: President Matthew P. Gourmand was appointed President a | Oct 1, 2026 |
| BNBX | 8-K | neutral | 4/10 | BNB Plus Corp. entered into a Second Amendment to its Registration Rights Agreement with holders of 50.1% or more of Reg | Oct 1, 2026 |
| VYLR | 8-K | neutral | 4/10 | Vylor Inc. (VYLR) completed its separation from Corteva, Inc. via a pro rata distribution of all outstanding Vylor share | Oct 1, 2026 |
| PRKR | 8-K | neutral | 4/10 | ParkerVision disclosed that the Federal Circuit dismissed its expedited appeal against Qualcomm for lack of jurisdiction | Oct 1, 2026 |
| SGP | 8-K | bullish | 6/10 | SpyGlass Pharma acquired 100% of Advanced Vision Science, Inc. (AVS) from Santen for $13M in cash, securing its IOL manu | Oct 1, 2026 |
| OBIO | 8-K | bullish | 6/10 | Orchestra BioMed announced that its BACKBEAT global pivotal trial of AVIM Therapy has exceeded full enrollment, with 330 | Oct 1, 2026 |
| CTVA | 8-K | neutral | 5/10 | Corteva completed the previously announced separation of its seed operating segment into an independent, publicly traded | Oct 1, 2026 |
| FRME | 8-K | neutral | 2/10 | First Merchants Corporation announced the planned retirement of CEO Mark Hardwick effective January 1, 2027, with curren | Oct 1, 2026 |
| AZTR | 8-K | neutral | 4/10 | Azitra announced that its Phase 1/2 trial of ATR-04 for EGFR inhibitor-associated skin rash has cleared the safety revie | Oct 1, 2026 |
| SEV | 8-K | bullish | 6/10 | Aptera Motors announced a significant reduction in its estimated capital requirements to reach production, driven by its | Oct 1, 2026 |
| AIRG | 8-K | neutral | 2/10 | Airgain appointed Stephan D. Memmen as a Class II independent director, effective October 1, 2026, increasing the board | Oct 1, 2026 |
| EVMN | 8-K | bullish | 7/10 | Evommune presented late-breaking Phase 2a proof-of-concept data for EVO301 in atopic dermatitis at the EADV 2026 Congres | Oct 1, 2026 |
| MSTR | 8-K | neutral | 3/10 | Strategy Inc filed an 8-K confirming a 12.00% dividend rate on its Variable Rate Series A Perpetual Stretch Preferred St | Oct 1, 2026 |
| ALLR | 8-K | neutral | 3/10 | Allarity Therapeutics issued a press release highlighting recent advances in its Drug Response Predictor (DRP) technolog | Oct 1, 2026 |
| INIS | 8-K | bullish | 6/10 | Radnostix (INIS) signed a definitive asset purchase agreement to sell its DUF6 deconversion and fluorine extraction asse | Oct 1, 2026 |
| NKTR | 8-K | bullish | 6/10 | Nektar Therapeutics presented new Phase 2b data for rezpegaldesleukin at EADV 2026, showing durable and deepening respon | Oct 1, 2026 |
| USAR | 8-K | neutral | 3/10 | USA Rare Earth filed an 8-K announcing the completion of its CEO transition, with Thras Moraitis (formerly President) as | Oct 1, 2026 |
| VERI | 8-K | bearish | 6/10 | Veritone entered into a securities purchase agreement for a registered direct offering of 20,000,000 shares of common st | Oct 1, 2026 |
| TOST | 8-K | neutral | 3/10 | Toast's Chief Revenue Officer Jonathan Vassil notified the company of his planned retirement, effective December 31, 202 | Oct 1, 2026 |
| BTLN | 8-K | neutral | 4/10 | Brightline Interactive closed a previously announced PIPE offering, raising $1.25 million in gross proceeds from the sal | Oct 1, 2026 |
| VBIO | 8-K | neutral | 3/10 | Valion Bio announced the successful completion of formulation work to develop an oral mucosal version of its lead candid | Oct 1, 2026 |
| VYLR | 8-K | neutral | 3/10 | Vylor Inc. announced the final results of its private exchange offers for three series of EIDP senior notes totaling $1. | Oct 1, 2026 |